Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
03/2006
03/02/2006WO2005120477A3 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
03/02/2006WO2004110364A3 Thiotungstate analogues and uses thereof
03/02/2006US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection
03/02/2006CA2578115A1 O-aminophenol derivatives and dyes containing these compounds
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006CA2577177A1 Oxopiperidine derivatives, preparation and therapeutic use thereof
03/02/2006CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
03/01/2006EP1628965A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
03/01/2006EP1628964A1 2-[2-[4-[(4-chlorophenyl) phenylmethyl] -1-piperazinyl] ethoxy] acetic acid monohydrochloride as anti-allergenic compound and process for its production
03/01/2006CN1742017A Antiprotozoal ring-substituted phospholipids
03/01/2006CN1742002A Novel piperazine derivatives and their use as synthesis intermediates
03/01/2006CN1741984A CaSR antagonist
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
02/2006
02/28/2006US7005520 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs
02/28/2006US7005437 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions
02/28/2006US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/23/2006WO2006018673A1 Method for determining the level of histamine in halieutic products
02/23/2006WO2006018326A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
02/23/2006WO2006018249A1 Method for the production of quarternary ammonia compounds at atmospheric pressure
02/23/2006WO2005110980A3 Aryl sulfones and uses related thereto
02/23/2006WO2005080324A8 Sulfonamide derivatives for the treatment of diseases
02/23/2006US20060041169 Preparation of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
02/23/2006US20060041141 4-Methylpropiophenone is reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid serving as a catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification
02/23/2006US20060041020 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase
02/23/2006US20060040952 Il-8 receptor antagonists
02/23/2006US20060040939 Benzamide inhibitors of the P2X, receptor
02/23/2006CA2575033A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
02/22/2006EP1627880A1 Boronic ester and acid compounds, synthesis and uses
02/22/2006EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/22/2006CN1738799A Methods for preparing phenylalkyne derivatives
02/22/2006CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication
02/22/2006CN1736994A Azo hetercyle beta-elemene derivative and its preparation method and uses
02/22/2006CN1736993A Intermediate compound used in synthesizing azo hetercyle beta-elemene derivative and its preparation method
02/22/2006CN1736991A Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses
02/22/2006CN1736980A Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
02/22/2006CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups
02/22/2006CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
02/21/2006US7002042 Cationic liposomes for gene transfer
02/21/2006US7001918 7-pyrrolyl tetracycline compounds and methods of use thereof
02/21/2006US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
02/21/2006US7001908 Arylpiperazines having activity at the serotonin 1A receptor
02/21/2006US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
02/21/2006US7001905 Substituted diarylamines as MEK inhibitors
02/21/2006CA2251090C Phenylethanolaminotetralincarboxamide derivatives
02/16/2006WO2006017406A1 Cyanoamidine p2x7 antagonists for the treatment of pain
02/16/2006WO2006015780A1 Method for improving a piperazine colour stability
02/16/2006WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders
02/16/2006US20060035137 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
02/16/2006DE102004032878A1 Verwendung von Alkyloxyalkansäureamiden insbesondere als Aromastoffe sowie neue Alkyloxyalkansäureamide Use of Alkyloxyalkansäureamiden especially as flavorings and new Alkyloxyalkansäureamide
02/16/2006DE102004030645A1 Production of ethylene amine compounds used e.g. as intermediates for pharmaceuticals comprises continuous reaction of ethylenediamine in presence of heterogeneous catalyst in reaction column
02/16/2006CA2575808A1 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
02/15/2006EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders
02/15/2006EP1625133A2 Nitrogen-containing monodentate phosphines and their use in catalysis
02/15/2006EP1625112A1 Novel compounds for treatment of obesity
02/15/2006EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES
02/15/2006CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
02/15/2006CN1735599A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
02/15/2006CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
02/15/2006CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound
02/15/2006CN1241882C Method for hydrogenating organic compounds by means of RU/SIO2 catalysts
02/15/2006CN1241683C Synthesis of 1,4-oxygen nitrogen heterocyclic hexane catalyst by ammonification of diethylene glycol and process thereof
02/14/2006US6998416 Cyclic AMP-specific phosphodiesterase inhibitors
02/14/2006US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics
02/14/2006CA2180155C Naphthylamides as central nervous system agents
02/09/2006WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006014133A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
02/09/2006WO2006014012A2 Aromatic compounds
02/09/2006US20060030599 Sulphonamide derivatives
02/09/2006US20060030569 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
02/09/2006US20060030554 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/09/2006CA2573223A1 Aromatic compound
02/08/2006EP1623973A1 Platinum complex
02/08/2006EP1622870A2 Glutaminyl based dp iv-inhibitors
02/08/2006EP1622867A1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
02/08/2006EP1622865A2 Novel bioisosteres of actinonin
02/08/2006EP1622606A1 Quaternary ammonium compounds and their use as antimuscarinic agents
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/08/2006EP1187815B1 4-phenyl-pyrimidine derivatives
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/08/2006CN1732006A 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
02/08/2006CN1730476A Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses
02/08/2006CN1730475A Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses
02/08/2006CN1240692C Method for the production of biperidin
02/08/2006CN1240677C Monofluoroalkyl derivatives
02/08/2006CN1240474C Preparation of 1,4-oxygen nitrogen heterocyclic hexane catalyst by ammonification of diethylene glycol and process thereof
02/07/2006US6995283 Benzophenones as inhibitors of reverse transcriptase
02/07/2006US6995269 Guanidinobenzamides
02/07/2006US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
02/07/2006US6995178 Insecticidal anthranilamides
02/07/2006US6995174 for inhibiting proteases
02/07/2006US6995156 Platelet adenosine diphosphate receptor antagonists